[1] |
Zhu N, Zhang D, Wang W , et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020,382:727-733.
doi: 10.1056/NEJMoa2001017
URL
pmid: 31978945
|
[2] |
Zhou P, Yang X L, Wang X G , et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020,579:270-273.
doi: 10.1038/s41586-020-2012-7
URL
pmid: 32015507
|
[3] |
Wu F, Zhao S, Yu B , et al. A new coronavirus associated with human respiratory disease in China[J]. Nature, 2020,579:265-269.
doi: 10.1038/s41586-020-2008-3
URL
pmid: 32015508
|
[4] |
Gorbalenya A E, Baker S C, Baric R S , et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2[J/OL]. Nat Microbiol, 2020-03-02, https://doi.org/10.1038/s41564-020-0695-z.
|
[5] |
Enserink M . Update: ‘A bit chaotic.’ Christening of new coronavirus and its disease name create confusion[J/OL]. Science, 2020-02-12, https://doi:10.1126/science.abb2806.
|
[6] |
World Health Organization. Coronavirus disease (COVID-19) outbreak [EB/OL].(2020- 03-11)[2020-03-13]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
|
[7] |
Nature news. Chinese virologists raise concerns about virus name[J/OL]. Nature, 2020-02-13, https://www.nature.com/articles/d41586-020-00154-w.
|
[8] |
Jiang S, Shi Z, Shu Y , et al. A distinct name is needed for the new coronavirus[J]. Lancet, 2020,395(10228):949.
doi: 10.1016/S0140-6736(20)30419-0
URL
pmid: 32087125
|
[9] |
Jiang S . Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees[J]. Nature, 2020,579:321.
doi: 10.1038/d41586-020-00751-9
URL
pmid: 32179860
|
[10] |
Gates B . Responding to Covid-19—A Once-in-a-Centu-ry Pandemic? [J]. N Engl J Med, 2020-02-28,DOI: 10.1056/NEJMp2003762.
|
[11] |
Xia S, Yan L, Xu W , et al. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike[J]. Sci Adv, 2019, 5(4):eaav4580.
|
[12] |
Jiang S, Du L, Shi Z . An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies[J]. Emerg Microb Infect, 2020,9:275-277.
doi: 10.1080/22221751.2020.1723441
URL
pmid: 32005086
|
[13] |
Jiang S, Shi Z . The first disease X is caused by a highly transmissible acute respiratory syndrome coronavirus[J/OL]. Virol Sin, 2020- 02- 14 , .
|
[14] |
Xia S, Liu M, Wang C , et al. Inhibiting SARS-CoV-2 infection by a highly potent pan-coronavirus fusion inhibitor targeting S protein with high capacity to mediate membrane fusion[J/OL]. Cell Res, accepted. bioRxiv, 2020- 03- 12 , http://doi.org/10.1101/2020.03.09.983247.
|
[15] |
Xia S, Zhu Y, Liu M , et al. Fusion mechanism of2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein[J/OL]. Cell Mol Immunol, 2020-02-11, https://doi.org/10.1038/s41423-020-0374-2.
|
[16] |
Wang M, Cao R, Zhang L , et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Res, 2020,30:269-271.
doi: 10.1038/s41422-020-0282-0
URL
pmid: 32020029
|
[17] |
Gautret P, Lagier J-C, Parola V P , et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial[J/OL]. Int J Antimicrob Agents,2020-03-20, https://doi.org/10.1016/j.ijantimicag.2020.105949.
|
[18] |
de Wit E, van Doremalen N, Falzarano D , et al. SARS and MERS: recent insights into emerging coronaviruses[J]. Nat Rev Microbiol, 2016,14:523-534.
doi: 10.1038/nrmicro.2016.81
URL
pmid: 27344959
|
[19] |
Guan W, Ni Z, Hu Y , et al. Clinical Characteristics of Coronavirus Disease 2019 in China[J]. N Engl J Med, 2020-02-28, DOI: 10.1056/NEJMoa2002032.
|
[20] |
Rothe C, Schunk M, Sothmann P , et al. Transmission of2019-nCoV Infection from an Asymptomatic Contact in Germany[J]. N Engl J Med, 2020-03-05,DOI: 10.1056/NEJMc2001468.
|
[21] |
Chan J F, Yuan S, Kok K H , et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster[J]. Lancet, 2020,395(10223):514-523.
doi: 10.1016/S0140-6736(20)30154-9
URL
pmid: 31986261
|
[22] |
Li Q, Guan X, Wu P , et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia[J]. N Engl J Med, 2020-01-29 ,DOI: 10.1056/NEJMoa2001316.
doi: 10.1056/NEJMoa2001316
URL
pmid: 31995857
|
[23] |
Huang C, Wang Y, Li X , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020,395(10223):497-506.
doi: 10.1016/S0140-6736(20)30183-5
URL
pmid: 31986264
|
[24] |
Wang C, Horby P W, Hayden F G , et al. A novel coronavirus outbreak of global health concern[J]. Lancet, 2020,395(10223):470-473.
doi: 10.1016/S0140-6736(20)30185-9
URL
pmid: 31986257
|
[25] |
Wang D, Hu B, Hu C , et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J/OL]. JAMA, 2020-02-07, https://doi:10.1001/jama.2020. 1585.
|
[26] |
Fauci A S, Lane H C, Redfield R R . Covid-19 — Navigating the Uncharted[J]. N Engl J Med, 2020-02-28,DOI: 10.1056/NEJMe2002387.
|
[27] |
Kupferschmidt K, Cohen J . Can China’s COVID-19 strategy work elsewhere?[J]. Science, 2020,367:1061-1062.
doi: 10.1126/science.367.6482.1061
URL
pmid: 32139521
|
[28] |
Alltucker K, O’Donnell J . When will the threat of coronavirus end? It might return every winter[N/OL]. (2020-02-06)[2020-03-11]. USA Today, https://www.usatoday.com/story/news/health/2020/02/06/coronavirus-wuhan-china-recurring-winter-illness-flu/4665482002.
|
[29] |
Jiang S, Xia S, Ying T , et al. A novel coronavirus (2019-nCoV) causing pneumonia associated respiratory syndrome[J/OL]. Cell Mol Immunol, 2020-02-05, https://doi.org/10.1038/s41423-020-0372-4.
|
[30] |
World Health Organization. WHO issues best practices for naming new human infectious diseases [EB/OL]. ( 2015- 05-08)[2020-03-13]. https://www.who.int/mediacentre/news/notes/2015/naming-new-diseases/en.
|